10x Genomics, Inc. (NASDAQ:TXG) Receives $31.60 Average PT from Analysts
10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the sixteen brokerages that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation, seven have assigned a buy recommendation and one has assigned […]
27 Sep 06:40 · The Markets Daily